We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSC
2426
DELISTED
MTS Systems Corp
MTSC
$1K ﹤0.01%
112
-144
-56% -$2.66K
DOC
2427
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1K ﹤0.01%
64
-38
-37% -$620
ACB
2428
Aurora Cannabis
ACB
$169M
$0 ﹤0.01%
4
-1
-20% -$114
ACRE
2429
Ares Commercial Real Estate
ACRE
$247M
-214
Closed -$3K
ACRS icon
2430
Aclaris Therapeutics
ACRS
$715M
$0 ﹤0.01%
74
AGNC icon
2431
AGNC Investment
AGNC
$12.7B
-197
Closed -$3K
ALKS icon
2432
Alkermes
ALKS
$8.11B
$0 ﹤0.01%
25
-472
-95% -$7.66K
ALL.PRB icon
2433
Allstate Corp 5.100% Fixed-To-Floating Rate Subordinated Debentures due 2053
ALL.PRB
$509M
-607
Closed -$15K
AMED
2434
DELISTED
Amedisys
AMED
$0 ﹤0.01%
5
-20,651
-100% -$3.85M
AMRX icon
2435
Amneal Pharmaceuticals
AMRX
$6.1B
-114
Closed
ANGI icon
2436
Angi Inc
ANGI
$247M
-2
Closed
APLS
2437
DELISTED
Apellis Pharmaceuticals
APLS
$0 ﹤0.01%
+29
New +$931
ARLO icon
2438
Arlo Technologies
ARLO
$1.58B
$0 ﹤0.01%
314
+60
+24% +$145
ARVN icon
2439
Arvinas
ARVN
$530M
$0 ﹤0.01%
+23
New +$976
ATI icon
2440
ATI
ATI
$24.3B
$0 ﹤0.01%
118
-120
-50% -$1.04K
ATRC icon
2441
AtriCure
ATRC
$2.08B
-29
Closed
ATRO icon
2442
Astronics
ATRO
$3.21B
$0 ﹤0.01%
34
-82
-71% -$641
BBIO icon
2443
BridgeBio Pharma
BBIO
$16.4B
-41
Closed -$1K
BBU
2444
DELISTED
Brookfield Business Partners
BBU
$0 ﹤0.01%
2
-3
-60% -$58
BBVA icon
2445
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
-6,144
Closed -$34K
BCDA icon
2446
BioCardia
BCDA
$11.5M
$0 ﹤0.01%
9
BCO icon
2447
Brink's
BCO
$5.01B
-9
Closed
BGC icon
2448
BGC Group
BGC
$5.64B
-4,500
Closed -$26K
BKE icon
2449
Buckle
BKE
$2.32B
-202
Closed -$5K
BKU icon
2450
Bankunited
BKU
$3.33B
-112
Closed -$4K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.